Get the Stockscreener App
23.14
1.07%
-0.25
Pre-market:
23.33
0.19
+0.82%
Surrozen Inc stock is traded at $23.14, with a volume of 183.25K.
It is down -1.07% in the last 24 hours and down -17.80% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
See More
Previous Close:
$23.39
Open:
$23.98
24h Volume:
183.25K
Relative Volume:
1.75
Market Cap:
$268.66M
Revenue:
$7.49M
Net Income/Loss:
$-360.50M
P/E Ratio:
-0.56
EPS:
-41.3227
Net Cash Flow:
$-33.68M
1W Performance:
+11.84%
1M Performance:
-17.80%
6M Performance:
+7.06%
1Y Performance:
+144.18%
1-Day Range:
$23.00
$25.12
1-Week Range:
$20.61
$25.13
52-Week Range:
$8.00
$35.00
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
23.14 | 268.66M | 7.49M | -360.50M | -33.68M | -41.32 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Initiated | TD Cowen | Buy |
| Feb-19-26 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
View All
Surrozen Inc Stock (SRZN) Latest News
SRZN Q1 2026 Earnings: Significant EPS Miss Reflects Operational ChallengesPeak Earnings Alert - newsline.com
Surrozen Warrants (SRZNW) Hold Steady at $0.02 Amidst Minimal MovementCovered Call ETF - newsline.com
SRZN Q1 2026 Earnings: Significant EPS Miss Amid Sharp Stock RallyGeographic Revenue Trends - newsline.com
Surrozen Inc. Warrant (SRZNW) Stabilizes at $0.02 Amid Minimal Trading ActivityPrice Surge Stocks - newsline.com
Surrozen Inc. Warrant (SRZNW): Price Stability at $0.02 Amid Minimal TradingNaked POC - newsline.com
SRZN Q1 2026 Earnings: Massive EPS Miss as Losses WidenFull Year Guidance - newsline.com
SRZN Q1 2026 Earnings: Dramatic EPS Miss of -945.97% Raises ConcernsProfit Warning Alert - newsline.com
Surrozen Warrant (SRZNW) Holds Flat at $0.02 as Trading Remains StagnantNaked POC - newsline.com
Surrozen Inc. Warrant (SRZNW) Surges 23% Amid Thin Trading – Key Levels to WatchBPI Bull Confirmed - The Legal Advocate
Surrozen Inc. (SRZN) Holds Steady Near Support as Consolidation ContinuesStop Hunt - The Legal Advocate
(SRZN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Total debt per share of Surrozen, Inc. – NASDAQ:SRZN - TradingView
Surrozen Inc. (SRZN) Edges Higher as Stock Tests Key Resistance Amid Low VolumeNegative Gamma - newsline.com
Surrozen Warrants (SRZNW) Plummet 16% to $0.02 – Evaluating Potential Risks and LevelsInsider Selling Alerts - The Legal Advocate
Number of shareholders of Surrozen, Inc. – NASDAQ:SRZN - TradingView
H.C. Wainwright Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $44 - Moomoo
Surrozen Q1 2026 Earnings: Staggering EPS Miss of -$11.65 Versus Estimate; Stock Declines 2.66%Non-GAAP Earnings - Newser
Surrozen Inc. (SRZN) Q1 2026 Earnings: Significant EPS Miss Reflects Ongoing Clinical-Stage Spending; No Revenue ReportedEBITDA Estimate Trend - The Legal Advocate
Surrozen Inc. (SRZN) Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock Edges HigherCommunity Watchlist Picks - Newser
What Does TCG Crossover GP II's Recent Buying Spree Mean for Surrozen (SRZN) - Kavout
We Think Surrozen (NASDAQ:SRZN) Can Afford To Drive Business Growth - Moomoo
Surrozen (SRZN) director and 10% owner receives options on 5,550 shares - Stock Titan
Surrozen (SRZN) major holder The Column Group discloses stakes up to 29.3% - Stock Titan
Surrozen (SRZN) Q1 2026 Results Miss Estimates — EPS $-11.65 vs $-1.11Top Trending Breakouts - Newser
We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Rate - Yahoo Finance
How (SRZN) Movements Inform Risk Allocation Models - Stock Traders Daily
Surrozen (SRZN) Drops -5.76% — Key Support at $26.74 2026-05-17Live Trade Sharing - Newser
SRZN Price Today: Surrozen, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Nantahala, Harkey & Mack report 225,772 SRZN shares (2.14%) — SRZN - Stock Titan
Venrock-led group reports 9.99% stake in Surrozen (SRZN) - Stock Titan
Chen Yu and TCG Funds Report 1.47M SRZN Shares (SRZN) - Stock Titan
5AM entities disclose 9.5% stake in Surrozen (NASDAQ: SRZN) and contingent shares - Stock Titan
[SCHEDULE 13G] Surrozen, Inc./DE Passive Investment Disclosure (>5%) - Stock Titan
Surrozen (SRZN) joint filing shows 525,639-share position, 4.5% stake - Stock Titan
Surrozen (SRZN) Q3 2025 Earnings: Miss Sparks ConcernElite Trading Signals - newser.com
Surrozen (SRZN) director receives 5,550 stock options at $30.14 strike - Stock Titan
Surrozen (SRZN) grants director David Woodhouse 5,550 stock options - Stock Titan
Surrozen Shareholders Support Board, Auditor and Pay Policies - TipRanks
Surrozen (SRZN) director awarded 5,550 options at $30.14 exercise price - Stock Titan
Director Christopher Chai gets 5,550 Surrozen (SRZN) stock options - Stock Titan
Surrozen (SRZN) director receives 5,550 stock options at $30.14 strike price - Stock Titan
Surrozen (SRZN) director receives grant of 5,550 stock options - Stock Titan
Surrozen (SRZN) investors approve directors, auditor and annual say-on-pay - Stock Titan
TradingKey - TradingKey
SRZN: All agenda items passed, including director elections and annual advisory votes on compensation - TradingView
Surrozen to Present at Upcoming Healthcare Investor Conference - The Manila Times
SRZNW Surrozen quarterly update shows clinical progress but no revenue as pipeline development continues.Global Trading Community - Newser
Lifesci Capital Has Strong Forecast for Surrozen Q2 Earnings - MarketBeat
HC Wainwright Estimates Surrozen's Q2 Earnings (NASDAQ:SRZN) - MarketBeat
The key driver behind Surrozen (SRZN) revenue growth | Q3 2025: EPS Misses ViewsMargin Compression - newser.com
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surrozen Inc Stock (SRZN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Williams Charles O | Chief Operating Officer |
May 04 '26 |
Sale |
33.33 |
2,036 |
67,866 |
16,571 |
| Parker Craig C | Chief Executive Officer |
May 04 '26 |
Sale |
33.33 |
4,524 |
150,798 |
16,553 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 24 '26 |
Buy |
24.69 |
106,658 |
2,633,717 |
736,554 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 23 '26 |
Buy |
24.90 |
15,223 |
379,051 |
683,225 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 13 '26 |
Buy |
24.88 |
35,433 |
881,463 |
675,018 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 12 '26 |
Buy |
24.99 |
12,374 |
309,166 |
657,301 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 16 '26 |
Buy |
24.99 |
1,190 |
29,733 |
675,613 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 11 '26 |
Buy |
23.57 |
17,763 |
418,763 |
650,567 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 12 '26 |
Buy |
23.86 |
1,093 |
26,082 |
651,114 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 03 '26 |
Buy |
21.94 |
4,355 |
95,549 |
641,685 |
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):